Clinical Trials Browser

Neuroendocrine Tumors × (177)Lu-DOTA-EB-TATE × Clear all

NCT05475210 2024-03-13

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

Phase 1 Recruiting

Neuroendocrine Tumors

NCT03478358 2022-08-31

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase 1 Unknown

Neuroendocrine Tumors

NCT03308682 2017-10-12

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Phase 1 Unknown

Neuroendocrine Tumors